BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28640517)

  • 1. Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy.
    Debes JD; Chan AJ; Balderramo D; Kikuchi L; Gonzalez Ballerga E; Prieto JE; Tapias M; Idrovo V; Davalos MB; Cairo F; Barreyro FJ; Paredes S; Hernandez N; Avendaño K; Diaz Ferrer J; Yang JD; Carrera E; Garcia JA; Mattos AZ; Hirsch BS; Gonçalves PT; Carrilho FJ; Roberts LR
    Liver Int; 2018 Jan; 38(1):136-143. PubMed ID: 28640517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
    Park JW; Chen M; Colombo M; Roberts LR; Schwartz M; Chen PJ; Kudo M; Johnson P; Wagner S; Orsini LS; Sherman M
    Liver Int; 2015 Sep; 35(9):2155-66. PubMed ID: 25752327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network.
    Farah M; Anugwom C; Ferrer JD; Baca EL; Mattos AZ; Possebon JPP; Arrese M; Prieto J; Balderramo D; Carrera E; Debes JD
    Ann Hepatol; 2023; 28(2):100876. PubMed ID: 36400386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
    Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
    World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
    Sherman M
    Semin Liver Dis; 2010 Feb; 30(1):3-16. PubMed ID: 20175029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria.
    Sinclair M; Roberts S; Kemp W; Knight V; Dev A; Gow P; Philpott H; Kronborg I; Arachchi NJ; Bell S; Lim L; Gorelik A; Nicoll A;
    Intern Med J; 2013 May; 43(5):501-6. PubMed ID: 23279328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study.
    Mgaieth S; Kemp W; Gow P; Fink M; Lubel J; Nicoll A; Gazzola A; Hong T; Ryan M; Knight V; Dev AT; Sood S; Bell S; Paul E; Roberts SK
    J Viral Hepat; 2017 Nov; 24(11):982-989. PubMed ID: 28414893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
    Yim SY; Seo YS; Jung CH; Kim TH; Lee JM; Kim ES; Keum B; Jong YK; An H; Kim JH; Yim HJ; Kim DS; Jeen YT; Yeon JE; Lee HS; Chun HJ; Byun KS; Um SH; Kim CD; Ryu HS
    Liver Int; 2016 Mar; 36(3):445-53. PubMed ID: 26352789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
    Tangutur NK; Medvedev SF; Regenstein F; Balart LA
    J La State Med Soc; 2011; 163(4):185-90. PubMed ID: 21954650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
    Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
    Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
    van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Yoon CH; Jin YJ; Lee JW
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1090-1096. PubMed ID: 29847489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
    Waziry R; Gomaa A; Waked I; Dore GJ
    Arab J Gastroenterol; 2018 Mar; 19(1):26-32. PubMed ID: 29506913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease.
    Huang Y; Wallace MC; Adams LA; MacQuillan G; Garas G; Ferguson J; Samuelson S; Tibballs J; Jeffrey GP
    J Clin Gastroenterol; 2018 Jul; 52(6):551-556. PubMed ID: 28858944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.
    Pinato DJ; Allara E; Chen TY; Trevisani F; Minguez B; Zoli M; Harris M; Dalla Pria A; Merchante N; Platt H; Jain M; Caturelli E; Kikuchi L; Pineda J; Nelson M; Farinati F; Rapaccini GL; Aytaman A; Yin M; Tan CK; Bower M; Giannini EG; Bräu N;
    J Clin Oncol; 2019 Feb; 37(4):296-304. PubMed ID: 30562130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.